SBIR grant supports Crinetics' development of kisspeptin receptor antagonists to treat PCOS Jan. 30, 2015
ProMetic receives clearance to start trial of PBI-4050 in metabolic-syndrome-associated diabetes Jan. 29, 2015
RSS